This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Yeda Research and Develpment & Co. Ltd, University of Washington. Active years: 2019-2020.
Company Filing History:
2 out of 1,168 
1 out of 2,169 
Years Active: 2019-2020
Title: Adi Goldenzweig: Innovator in Biochemical Research
Introduction
Adi Goldenzweig is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of biochemical research, particularly in the development of polypeptides and proteins that have applications in treating organophosphate exposure.
Latest Patents
Goldenzweig holds 2 patents, with her latest innovations focusing on isolated phosphotriesterase polypeptides and methods for designing stable proteins. One of her patents describes a genetically modified polypeptide that exhibits enhanced catalytic efficiency for V-type nerve agents. This polypeptide is characterized by an amino acid sequence that significantly improves its effectiveness in neutralizing harmful agents. Her second patent outlines a method for designing proteins with improved thermal stability and specific activity, which includes proteins that have multiple amino acid substitutions compared to their wild type counterparts.
Career Highlights
Throughout her career, Goldenzweig has worked with notable organizations such as Yeda Research and Development Company Ltd and the University of Washington. Her work has been instrumental in advancing the understanding of protein stability and functionality.
Collaborations
Goldenzweig has collaborated with esteemed colleagues, including Sarel Fleishman and Dan S Tawfik, contributing to a rich exchange of ideas and innovations in her field.
Conclusion
Adi Goldenzweig's contributions to biochemical research and her innovative patents highlight her role as a leading inventor in the scientific community. Her work continues to pave the way for advancements in the treatment of organophosphate-related damage.